Showing results (5591-5600 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|August 18, 2022
Tools in the Era of Multidrug Resistance in Bacteria: Applications for New Antimicrobial Peptides DiscoveryAntonio Moretta, Carmen Scieuzo, Rosanna Salvia, et al.Current Pharmaceutical Design|August 19, 2022
The Inhibitory Effect on Tumor Cells Proliferation Induced by Arsenic Through DNMTs and its Downstream Molecules: A Systematic Review and Meta-AnalysisJingyi Zhang, Sheng Li, Mingxiao Ma, et al.Current Pharmaceutical Design|August 23, 2022
New Ferrocene Formates Bearing Isoxazole Moieties: Synthesis, Characterization, X-ray Crystallography, and Preliminarily Cytotoxicity against A549, HCT116, and MCF-7 Cell LinesJianping Yong, Canzhong Lu, Minxue Yang, et al.Current Pharmaceutical Design|November 8, 2022
Current Insights and Molecular Docking Studies of the Drugs under Clinical Trial as RdRp Inhibitors in COVID-19 TreatmentIrine Pauly, Ankit Kumar Singh, Adarsh Kumar, et al.Current Pharmaceutical Design|April 14, 2020
The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human CarcinomasPeng-Fei Wang, Xiaoyu Wang, Min Liu, et al.Current Pharmaceutical Design|April 24, 2020
Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer's DiseaseAnmol Dogra, R S Narang, Jasjeet K NarangCurrent Pharmaceutical Design|May 31, 2020
Risk Models and Scores in Patients with Peripheral Artery Disease and Chronic Limb-threatening Ischemia: A Comprehensive ReviewDamianos G Kokkinidis, Adarsh Katamreddy, Stefanos Giannopoulos, et al.Current Pharmaceutical Design|June 1, 2020
Cardiovascular Complications in Patients with Turner's SyndromeEirini Kostopoulou, Julia K Bosdou, Panagiotis Anagnostis, et al.Current Pharmaceutical Design|June 5, 2020
A Comprehensive and Contemporary Review on Immunosuppression Therapy for Heart TransplantationLivia A Goldraich, Santiago A Tobar Leitão, Fernando L Scolari, et al.Current Pharmaceutical Design|September 17, 2021
Rational Design and Development of HDAC Inhibitors for Breast Cancer TreatmentDeepansh Mody, Julie Bouckaert, Savvas N Savvides, et al.Pageof 1,008